Literature DB >> 20121822

Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy.

M Cerquetti1, M Giufrè, A García-Fernández, M Accogli, D Fortini, I Luzzi, A Carattoli.   

Abstract

Quinolone and β-lactam resistance mechanisms and clonal relationships were characterized among Escherichia coli isolates resistant to ciprofloxacin and extended-spectrum cephalosporins associated with human extra-intestinal infections in Rome. The E. coli. ST131 clone was found to be prevalent. This clone invariably carried a specific pattern of substitutions in the topoisomerase genes and all isolates but one produced CTX-M-15. One ST131 isolate produced SHV-12. The new ST131 variant described here is of particular concern because it combines fluoroquinolone resistance and chromosomally encoded CTX-M-15.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20121822     DOI： 10.1111/j.1469-0691.2010.03162.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  19 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Authors:  Joanne L Platell; Rowland N Cobbold; James R Johnson; Anke Heisig; Peter Heisig; Connie Clabots; Michael A Kuskowski; Darren J Trott
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

3.  Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.

Authors:  Timothy Kudinha; James R Johnson; Scott D Andrew; Fanrong Kong; Peter Anderson; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

4.  Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Authors:  Aylin Colpan; Brian Johnston; Stephen Porter; Connie Clabots; Ruth Anway; Lao Thao; Michael A Kuskowski; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

5.  Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.

Authors:  Muhanad Mohamed; Kris Owens; Abby Gajewski; Connie Clabots; Brian Johnston; Paul Thuras; Michael A Kuskowski; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

6.  A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli.

Authors:  Kristin R Baker; Bimal Jana; Henrik Franzyk; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Authors:  James R Johnson; Veronika Tchesnokova; Brian Johnston; Connie Clabots; Pacita L Roberts; Mariya Billig; Kim Riddell; Peggy Rogers; Xuan Qin; Susan Butler-Wu; Lance B Price; Maliha Aziz; Marie-Hélène Nicolas-Chanoine; Chitrita Debroy; Ari Robicsek; Glen Hansen; Carl Urban; Joanne Platell; Darren J Trott; George Zhanel; Scott J Weissman; Brad T Cookson; Ferric C Fang; Ajit P Limaye; Delia Scholes; Sujay Chattopadhyay; David C Hooper; Evgeni V Sokurenko
Journal:  J Infect Dis       Date:  2013-01-03       Impact factor: 5.226

8.  Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries.

Authors:  R Izdebski; A Baraniak; J Fiett; A Adler; M Kazma; J Salomon; C Lawrence; A Rossini; A Salvia; J Vidal Samso; J Fierro; M Paul; Y Lerman; S Malhotra-Kumar; C Lammens; H Goossens; W Hryniewicz; C Brun-Buisson; Y Carmeli; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

9.  Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.

Authors:  Bente Olesen; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Brian Johnston; Dennis S Hansen; Flemming Scheutz; Karen A Krogfelt; Michael A Kuskowski; Connie Clabots; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

10.  Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coli.

Authors:  Kristin R Baker; Helga Høeg Sigurðardóttir; Bimal Jana; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.